31.41000 USD
0.06
0.19%
Last update Dec 15, 3:59 PM EST
Post-market
Day range
31
31.85000
Previous close
31.35000
Open
31
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
31.41
0.06
0.19%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 161.7M 141.1M 120.9M 108.2M
Cost of revenue 28.1M 18.9M 15.5M 15.4M
Gross profit 133.6M 122.2M 105.3M 92.8M
Operating expense
Research & development 40.9M 31.8M 46.4M 23.9M
Selling general and admin 63.4M 55.6M 50.3M 39.0M
Other operating expenses
Operating income 29.4M 34.8M 8.6M 29.9M
Non operating interest income
Income
Expense 6.7M 6.7M 6.8M 7.1M
Other income expense 3.3M 2.8M 3.6M 2.6M
Pretax income 25.9M 30.9M 5.5M 25.5M
Tax provision -365.0M 2.7M 408K 2.1M
Net income 390.9M 28.2M 5.1M 23.3M
Basic EPS 2.7 0.2 0.0 0.2
Diluted EPS 2.4 0.2 0.0 0.2
Basic average shares 145.4M 146.7M 146.7M 145.2M
Diluted average shares 161.0M 162.6M 162.8M 160.2M
EBITDA 32.7M 37.7M 12.3M 32.6M
Net income from continuing op. 390.9M 28.2M 5.1M 23.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 18 minutes

19:42
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).